Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Emergent Biosolutions (NY: EBS )

1.900 UNCHANGED
Streaming Delayed Price Updated: 7:00 PM EDT, Apr 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 30
Open 1.900
Bid (Size) 1.910 (1)
Ask (Size) 2.100 (6)
Prev. Close 1.900
Today's Range 1.900 - 1.900
52wk Range 1.420 - 11.66
Shares Outstanding 52,200,000
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
Appoints Abigail “Abbey” Jenkins, a veteran biotech executive with over 20 years of experience in commercial leadership, to Board of Directors 
From Aquestive Therapeutics, Inc.
Via GlobeNewswire
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
From Emergent BioSolutions
Via GlobeNewswire

Performance

YTD
-26.64%
-26.64%
1 Month
-23.08%
-23.08%
3 Month
-1.04%
-1.04%
6 Month
-17.75%
-17.75%
1 Year
-82.63%
-82.63%

More News

Read More
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
From Emergent BioSolutions
Via GlobeNewswire
Emergent BioSolutions: Q4 Earnings Insights
Via Benzinga
Emergent BioSolutions's Earnings: A Preview
Via Benzinga
Why HighPeak Energy Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
Why Rush Street Interactive Shares Are Trading Higher By Around 25%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Is Emergent BioSolutions (EBS) Stock Up 70% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript
Via The Motley Fool
Topics Earnings
Exposures Financial
EBS Stock Earnings: Emergent BioSolutions Misses EPS, Misses Revenue for Q4 2023
Via InvestorPlace
Emergent BioSolutions Reports Q4 Results, Amends Credit Agreement
Via Benzinga
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
From Emergent BioSolutions
Via GlobeNewswire
Earnings Scheduled For March 6, 2024
Via Benzinga
Earnings Scheduled For March 5, 2024
Via Benzinga
Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024
From Emergent BioSolutions
Via GlobeNewswire
What's Going On Emergent BioSolutions Shares Today?
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Intraday Session
Via Benzinga
Emergent BioSolutions Inc. (NYSE: EBS) is One of Wednesday Morning’s Most Active Stocks
Via Investor Brand Network
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why International Flavors & Fragrances Shares Are Trading Lower By Around 8%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
Emergent BioSolutions Appoints Industry Leader Joseph C. Papa as New President and CEO
From Emergent BioSolutions
Via GlobeNewswire
Contrarian Calls: 7 Analyst ‘Sell’ Ratings That Should Be ‘Buys’
Via InvestorPlace
Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense
From Emergent BioSolutions
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.